Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Opt Lett ; 40(17): 3949-52, 2015 Sep 01.
Article in English | MEDLINE | ID: mdl-26368683

ABSTRACT

We report on individual wavelength locking of a multiplet of 100-µm broad-area laser diode emitters arranged on a 50% fill-factor bar by means of a single external multi-laser cavity using an ultra-narrowband thin-film filter as a dispersive optical element. The achieved wavelength-locked output power is 216 W, corresponding to an electrical-to-optical conversion efficiency of about 49.7%. The 45 emitters of the laser diode bar are stabilized within a spectral range of about 6.4 nm. Our approach is suited for killowatt-class dense wavelength beam combining of direct diode lasers.

2.
Z Gerontol Geriatr ; 36(4): 297-302, 2003 Aug.
Article in German | MEDLINE | ID: mdl-12937935

ABSTRACT

This article is about the results of a literature analysis, focusing on the two questions: 1) What is the understanding of "Chronic confusion"? and 2) How is the nursing diagnosis "Chronic confusion" delineated from the diagnosis "Dementia"? The review is based on the databases CINAHL, MEDLINE and GEROLIT. A review of the literature revealed that there is basic agreement regarding the characteristic "cognitive impairment" but there are differences in the question as to how this cognitive impairment manifests itself in practice. Moreover most authors described socially and emotionally altered behaviors which accompany the phenomenon. There is, however, no clear vision on the status of such socially and emotionally altered behaviors: Do they have to be present for "Chronic confusion" to be diagnosed or not? In addition, it seems inconsistent to include the mild stage of Dementia in the "Chronic confusion" diagnosis. This analysis indicates that much work remains to be done to validate the characteristics of "Chronic confusion". As long as the diagnosis is not clear, imprecise labeling of patients and ineffective interventions cannot be avoided.


Subject(s)
Confusion/diagnosis , Dementia/diagnosis , Nursing Diagnosis , Chronic Disease , Cognition Disorders/diagnosis , Delirium/diagnosis , Diagnosis, Differential , Humans , Terminology as Topic , Time Factors
3.
Epilepsia ; 42 Suppl 3: 76-80, 2001.
Article in English | MEDLINE | ID: mdl-11520330

ABSTRACT

The knowledge of patients with epilepsy about their own condition is poor, and thus the need for educational programs for people with epilepsy has long been recognized. However, no such programs have been established in their routine care. The Modular Service Package Epilepsy (MOSES) now tries to fill this gap for patients in German-speaking countries. The program was developed by a multidisciplinary group (neurologists, nonmedical professional helpers, and representatives of national epilepsy associations) for people with epilepsy older than 16 years, independent of the kind and severity of their epilepsy. MOSES is designed for group education and can be used in inpatient and outpatient settings in epilepsy centers, in clinics, and by neurologists in private practice. The program aims to help patients achieve a better understanding of their disease, to gain more self-confidence, and to take over responsibility, thus supporting patients to become experts in managing their own illness. Being modular in structure, MOSES includes nine units: living with epilepsy, epidemiology, basic knowledge, diagnostics, therapy, self-control, prognosis, psychosocial aspects, and network epilepsy. MOSES consists of a workout manual for patients and a trainer manual. For potential trainers, special "train-the-trainer seminars" are offered and considered mandatory. About 400 patients have participated in a MOSES training program in Germany, Switzerland, and Austria. The efficacy of the program is currently been evaluated.


Subject(s)
Epilepsy/psychology , Epilepsy/therapy , Family/psychology , Patient Education as Topic/methods , Attitude to Health , Austria , Epilepsy/epidemiology , Female , Germany/epidemiology , Health Knowledge, Attitudes, Practice , Humans , Male , Patient Education as Topic/organization & administration , Patient Selection , Pilot Projects , Program Development/methods , Switzerland , Teaching Materials
5.
Santiago de Chile; s.n; 2001. 72 p. tab, graf.
Thesis in Spanish | LILACS | ID: lil-340141

ABSTRACT

El desayuno constituye la comida más importante del día, sobre todo en los escolares por sus implicancias para el desarrollo físico e intelectual. En Chile existen políticas nacionales destinadas a mejorar la alimentación escolar, sin embargo su énfasis está en el almuerzo. Por este motivo surge la necesidad de conocer las características del desayuno recibido por los escolares de la comuna de La Pintana. El universo son niños de sexto básico de escuelas municipales (1.623) y la muestra corresponde al 15 por ciento, a los cuales se aplicó un cuestionario. La población estudiada mayoritariamente son mujeres (54 por ciento), la edad promedio fue de 11,5 años y pertenecen a familias de bajo estrato socioeconómico. La comida más importante referida por los niños (72,1 por ciento) fue el desayuno. La mayoría toma habitualmente desayuno (75,3 por ciento), y el día en que se aplicó el cuestionario cerca del 85 por ciento de la población había ingerido este alimento preparado por sus madres. Al valorar el estado nutricional de la población, el 55,6 por ciento se encuentra en un estado normal y el 41,9 por ciento se distribuye entre sobrepeso y obesidad. Al analizar la ingesta calórica del desayuno de ese día. sólo al 45 por ciento ingirió las calorías recomendadas. Un 58 por ciento de los niños sobrepasó el consumo de hidratos de carbono, el 67 por ciento presentó una ingesta normal de proteínas y un 76 por ciento consumió menos lípidos. Se sugiere a la enfermera conformar un equipo multidisciplinario para intervenir en edades más tempranas, con el fín de promover conductas alimentarias saludables que incluyan el desayuno valorando su importancia


Subject(s)
Humans , Male , Female , Nursing Care/methods , Child Nutrition , School Feeding , Diet , Feeding Behavior
6.
Epilepsia ; 41 Suppl 5: S37-44, 2000.
Article in English | MEDLINE | ID: mdl-11045437

ABSTRACT

A recent United Kingdom cost minimization analysis (CMA) of four antiepileptic drugs (AEDs) used to treat newly diagnosed adult epilepsy demonstrated that a new drug, lamotrigine (LTG), incurred higher costs than carbamazepine (CBZ), phenytoin (PHT), and valproate (VPA), whose costs were similar. This analysis took account of each drug's side-effect and tolerability profile. The present analysis investigated the costs of treatment with LTG, CBZ, PHT, and VPA in 12 European countries. Data were derived from published sources and from a panel of locally based experts. When no published data were available, estimates were obtained using expert opinion by a consensus method. These data were incorporated into a treatment pathway model, which considered the treatment of patients during the first 12 months after diagnosis. The primary outcome considered was seizure freedom. Randomized controlled trials demonstrate that the drugs considered are equally effective in terms of their ability to achieve seizure freedom, and thus the most appropriate form of economic evaluation is a CMA. These trials provided data on the incidence of side effects, dosages, and retention rates. The economic perspective taken was that of society as a whole and the analysis was calculated on an "intent-to-treat" basis. Only direct medical costs were considered. In each country considered, LTG was twofold to threefold more expensive than the other drugs considered. A sensitivity analysis demonstrated that varying each of the assumptions (range defined by expert panels) did not significantly alter the results obtained.


Subject(s)
Anticonvulsants/economics , Anticonvulsants/therapeutic use , Epilepsy/drug therapy , Health Care Costs , Anticonvulsants/adverse effects , Cost Control , Cost of Illness , Cost-Benefit Analysis , Drug Costs , Epilepsy/economics , Epilepsy/epidemiology , Europe/epidemiology , Health Expenditures , Humans , National Health Programs/economics , National Health Programs/statistics & numerical data , Quality of Life , Randomized Controlled Trials as Topic/statistics & numerical data , Treatment Outcome , United Kingdom/epidemiology
7.
Epilepsia ; 41 Suppl 3: S2-9, 2000.
Article in English | MEDLINE | ID: mdl-11001330

ABSTRACT

The diagnostic goals in nonsurgical (conservative) epileptology differ from presurgical diagnostic aims. The resulting development of diagnostic methods in a tertiary-level epilepsy center is shown and the major technical and organizational consequences of this difference for diagnostic long-term monitoring (LTM) as opposed to presurgical LTM are investigated. A total of 133 consecutive daytime LTM investigations using radio telemetry were reviewed and seizure parameters such as type, duration, method of seizure detection, and need of mobility were evaluated and compared to presurgical LTM. Compared to presurgical LTM, partial seizures were relatively rare (17.8%) and short epileptic or nonepileptic motor events lasting <1 s, such as myoclonic, atonic, short tonic seizures, spasms, tics, or startle reactions, are frequent (34.9%). Of all seizures, 23% had no or minor ictal EEG changes, subtle symptomatology without signaling by a patient or accompanying person, and could be detected only by continuous online surveillance by an experienced EEG technician. Due to the nature of the patient population in diagnostic LTM, there is an increased need for ictal and interictal mobility (radio telemetry). LTM in conservative epileptology requires more intense human surveillance for seizure detection and increased patient mobility compared to presurgical LTM.


Subject(s)
Electroencephalography/methods , Epilepsy/diagnosis , Monitoring, Physiologic/methods , Adolescent , Adult , Aged , Child , Child, Preschool , Electroencephalography/statistics & numerical data , Humans , Infant , Middle Aged , Monitoring, Physiologic/statistics & numerical data , Radio , Telemetry/methods , Telemetry/statistics & numerical data
8.
Pediatr Rehabil ; 3(2): 43-51, 1999.
Article in English | MEDLINE | ID: mdl-10509350

ABSTRACT

OBJECTIVE: To examine the medical and functional outcome of paediatric stroke survivors. PATIENTS: Patients aged 1 month to 18 years diagnosed with stroke over a 10 year period. MAIN OUTCOME MEASURES: Discharge functional outcome data were collected by reviewing therapy, nursing, and other chart notes relating to specific functional tasks. Current functional information, living situation, school placement, and medical outcome data were obtained in the telephone survey. RESULTS: Fifty patients responded. The mean age at event was 8.0 years (range: 7 months to 17 years, 7 months). The mean follow-up time was 70 months. Diagnoses included: haemorrhagic (30%), thrombotic/embolic (46%), and undiagnosed (24%). At follow-up, 76% of the patients were independent in all activities of daily living (ADL), compared to 64% at hospital discharge. Younger age at onset, female gender, history of cardiac disease, and presentation with hemiparesis were significant risk factors for dependence in ADL (p < 0.05), while thrombotic/embolic aetiology demonstrated a trend (p = 0.06). Eighty-four per cent were independent in mobility, compared to 74% at discharge. Forty per cent of the patients had speech and language deficits. Of the school age children, only 50% were in a regular classroom. CONCLUSIONS: Children and adolescents who survive stroke have good outcome for mobility and ADL skills, but more difficulty with language and cognitive recovery. Functional recovery is maintained after discharge, and functional gains occur over time with very little evidence of functional regression. Comorbidities are relatively low. All children in the group returned to a home setting.


Subject(s)
Activities of Daily Living , Cerebrovascular Disorders/rehabilitation , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Retrospective Studies , Treatment Outcome
9.
J Biol Chem ; 274(23): 16377-86, 1999 Jun 04.
Article in English | MEDLINE | ID: mdl-10347197

ABSTRACT

Hepatocyte growth factor/scatter factor (HGF/SF) is a pleiotropic effector inducing invasion and metastasis of tumor cells that express the Met tyrosine kinase receptor. One of the effectors of HGF/SF is the urokinase-type plasminogen activator, a serine protease that facilitates tumor progression and metastasis by controlling the synthesis of the extracellular matrix degrading plasmin. Stimulation of NIH 3T3 cells that were stably transfected with the human Met receptor (NIH 3T3-Methum) with HGF/SF induced a trans-activation of the urokinase promoter and urokinase secretion. Induction of the urokinase promoter by HGF/SF via the Met receptor was blocked by co-expression of a dominant-negative Grb2 and Sos1 expression construct. Further, the expression of the catalytically inactive mutants of Ha-Ras, RhoA, c-Raf, and Erk2 or addition of the Mek1-specific inhibitor PD 098059 abrogated the stimulation of the urokinase promoter by HGF/SF. A sequence residing between -2109 and -1870 base pairs (bp) was critical for stimulation of the urokinase gene by HGF/SF. Mobility shift assays with oligonucleotides spanning an AP-1 site at -1880 bp or a combined PEA3/AP-1 site at -1967 bp showed binding of nuclear factors from NIH 3T3-Methum cells. Expression of an expression plasmid that inhibits DNA binding of AP-1 proteins (A-Fos) abrogated inducible and basal activation of the urokinase promoter. Nuclear extract from unstimulated NIH 3T3-Methum cells contained more JunD and showed a stronger JunD supershift with the AP-1 oligonucleotides, compared with HGF/SF-stimulated cells. Consistent with the levels of JunD expression being functionally important for basal expression of the urokinase promoter, we found that overexpression of wild type JunD inhibited the induction of the urokinase promoter by HGF/SF. These data suggest that the induction of urokinase by HGF/SF is regulated by a Grb2/Sos1/Ha-Ras/c-Raf/RhoA/Mek1/Erk2/c-++ +Jun-dependent mitogen-activated protein kinase pathway.


Subject(s)
Gene Expression Regulation, Enzymologic , Hepatocyte Growth Factor/metabolism , Promoter Regions, Genetic , Protein Precursors/metabolism , Urokinase-Type Plasminogen Activator/genetics , 3T3 Cells , Animals , DNA/metabolism , Enzyme Activation , Humans , Mice , Proto-Oncogene Proteins c-met/metabolism , Signal Transduction , Transcription Factor AP-1/metabolism , Up-Regulation , Urokinase-Type Plasminogen Activator/metabolism
10.
Brain ; 121 ( Pt 8): 1409-27, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9712004

ABSTRACT

We present the clinical and electrographic data of 17 patients with reading-induced seizures documented with ictal video-EEG studies during provocation with language related tasks. The median age at onset was 15 years (range 11-22 years) and the male:female ratio was 2.4. Fourteen patients had no spontaneous seizures of any type while the remaining three had infrequent generalized tonic-clonic seizures during nocturnal sleep. Two distinct electroclinical ictal patterns were confirmed on video-EEG analysis. (i) Fifteen patients had reading-induced jerks which invariably involved the region of the jaw but also included the upper limbs in five of them. Ictal EEG discharges were noted in 12 patients; these were brief but varied in terms of morphology and spatial distribution, with a clear tendency for left-sided predominance. All but one of these patients had similar myoclonic seizures induced by linguistic activities other than reading, the phenomenon probably justifying the term 'language-induced epilepsy'. Some patients had evidence of transient cognitive impairment associated with the reading-induced jaw or limb jerks. Three patients had a sibling with reading epilepsy but there was no other family history of epileptic seizures. (ii) Two patients had reading-provoked paroxysmal alexia without motor symptoms, associated with prolonged focal ictal EEG abnormalities. Reading provoked a subclinical, continuous and reproducible EEG activation over the left posterior temporal area. We propose that ictogenesis in reading or language-induced epilepsy is based on the reflex activation of a hyperexcitable network that subserves the function of speech and extends over multiple cerebral areas on both hemispheres. The parts of this network responding to the stimulus may, secondarily, drive the relative motor areas producing the typical regional myoclonus. This network hyperexcitability can be genetically determined and its clinical expression is age-related.


Subject(s)
Epilepsy/classification , Epilepsy/etiology , Reading , Adolescent , Adult , Anticonvulsants/therapeutic use , Brain/pathology , Child , Electroencephalography , Epilepsy/genetics , Epilepsy/physiopathology , Female , Humans , Magnetic Resonance Imaging , Male , Medical Records , Television , Temporal Lobe/physiopathology , Time Factors , Treatment Outcome
11.
Epilepsy Res ; 29(3): 251-7, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9551786

ABSTRACT

The pathophysiological and neuroanatomical bases of reading epilepsy (RE) are unclear. We performed video-EEG, high quality MRI and [11C]diprenorphine PET in a patient with RE to detect structural and functional abnormalities. EEG showed multifocal seizure onset bilaterally in temporal and fronto-central regions. MRI was normal, whereas [11C]diprenorphine PET revealed peri-ictal opioid binding decreases in both temporal lobes and the left frontal lobe. These findings confirm that RE is due to abnormal activity in the network subserving reading.


Subject(s)
Brain/physiopathology , Epilepsies, Myoclonic/physiopathology , Reading , Adult , Brain/diagnostic imaging , Brain/pathology , Carbon Radioisotopes/pharmacokinetics , Diprenorphine/pharmacokinetics , Electroencephalography , Epilepsies, Myoclonic/diagnostic imaging , Epilepsies, Myoclonic/pathology , Female , Functional Laterality , Humans , Magnetic Resonance Imaging , Tomography, Emission-Computed
12.
Neurology ; 48(5): 1394-7, 1997 May.
Article in English | MEDLINE | ID: mdl-9153479

ABSTRACT

A previous suggestion that antiepileptic drugs may induce color vision deficiencies prompted us to examine whether color vision deficiencies may occur at lower drug serum concentrations than those associated with symptoms of neurotoxicity. Eighty patients presenting with epilepsy received monotherapies of valproic acid, phenytoin, or carbamazepine; 18 patients did not receive antiepileptic drug therapy. Color vision was tested by the Farnsworth-Munsell 100-hue test, spectral sensitivity, and the newly developed tritan screening plates. Patients treated with phenytoin or carbamazepine developed blue-yellow color vision deficiencies. In contrast, patients exposed to valproic acid or receiving no drug treatment showed normal color vision. There was a significant correlation (p < 0.0001) between signs of neurotoxicity induced by phenytoin or carbamazepine and blue-yellow color vision deficiencies. In contrast, we found no correlation between these signs of neurotoxicity and the drug serum concentrations (p = 0.0637). Color vision testing in epileptic patients treated with phenytoin or carbamazepine appears to be a sensitive method for early detection and monitoring of clinical neurotoxicity.


Subject(s)
Anticonvulsants/adverse effects , Color Perception/drug effects , Vision Disorders/chemically induced , Vision Tests , Adolescent , Adult , Anticonvulsants/blood , Anticonvulsants/therapeutic use , Carbamazepine/adverse effects , Carbamazepine/blood , Carbamazepine/therapeutic use , Epilepsy/drug therapy , Humans , Osmolar Concentration , Phenytoin/adverse effects , Phenytoin/blood , Phenytoin/therapeutic use , Valproic Acid/adverse effects , Valproic Acid/blood , Valproic Acid/therapeutic use
13.
Epilepsia ; 38(11): 1221-6, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9579924

ABSTRACT

PURPOSE: The relationship between seizure frequency and both health care costs and quality of life (QOL) was investigated in a retrospective, cross-sectional, multicenter study in France, Germany, and the United Kingdom. METHODS: Three hundred outpatients with stable partial epilepsy were approximately evenly distributed among five seizure-frequency groups, ranging from seizure-free in the last 3 months (group 1) to daily seizures (group 5). Economic data, obtained through patient interviews and record abstraction, comprised direct medical costs, direct nonmedical costs, and indirect costs for the preceding 3 months. Total societal costs in the three countries were pooled and converted to United States dollar equivalents. QOL was assessed through a self-administered questionnaire, the Functional Status Questionnaire (FSQ). RESULTS: Mean total costs increased from $780 in group 1 to $2,171 in group 5 (p = 0.0001), with significant increases in each cost category as seizure frequency increased. Greater seizure frequency also significantly (p = 0.0270) correlated with lower employment rates, which ranged from 57% in group 1 to 30% in group 5. QOL declined as seizure frequency increased. Particularly affected were basic and intermediate activities of daily living (ADL), mental health, social activity, and feeling about health. CONCLUSIONS: The study results show that higher seizure frequencies are associated with higher direct and indirect costs and with reduced QOL for patients with epilepsy.


Subject(s)
Ambulatory Care , Epilepsies, Partial/economics , Epilepsies, Partial/epidemiology , Health Care Costs , Quality of Life , Adolescent , Adult , Ambulatory Care/economics , Caregivers/economics , Cost of Illness , Cross-Sectional Studies , Direct Service Costs , Female , France/epidemiology , Germany/epidemiology , Humans , Male , Middle Aged , Retrospective Studies , Social Support , Transportation/economics , United Kingdom/epidemiology
15.
Ophthalmologe ; 92(2): 182-90, 1995 Apr.
Article in German | MEDLINE | ID: mdl-7780278

ABSTRACT

Advanced psychophysical tests, performed in 42 patients who have seizures, showed that the widely used antiepileptic drugs, diphenylhydantoin and carbamazepine, can specifically affect retinal function, while valproic acid and the epileptic seizures do not. The Farnsworth-Munsell 100-Hue and Panel D-15 désaturé tests revealed an accumulation of errors along the tritan/tetartan axis and a high total error score. As shown by measurement of the so-called transient tritanopia and by determination of the spectral sensitivity, this blue vision defect is not only due to loss of postreceptoral interaction between long- and short-wavelength-sensitive cones, but is also based on a disturbance in the receptor mechanism itself. The dark adaptation curve was not affected. As determined by cone flicker thresholds during dark adaptation, the inhibitory action of rods on cones is reduced. The results obtained for mesopic vision and especially glare sensitivity measured by nyktometry were markedly affected in these patients compared to the normal population. The psychophysical methods provide a very sensitive test for early detection of drug-induced retinal dysfunction and allow clear differentiation between the loss of a receptor mechanism and a defect in the neuronal interaction between photoreceptors in the human visual system induced by antiepileptics.


Subject(s)
Anticonvulsants/adverse effects , Epilepsy/drug therapy , Retina/drug effects , Visual Perception/drug effects , Adolescent , Adult , Anticonvulsants/therapeutic use , Carbamazepine/adverse effects , Carbamazepine/therapeutic use , Child , Color Perception/drug effects , Contrast Sensitivity/drug effects , Dark Adaptation/drug effects , Female , Flicker Fusion/drug effects , Humans , Male , Phenytoin/adverse effects , Phenytoin/therapeutic use , Psychophysics , Sensory Thresholds/drug effects , Valproic Acid/adverse effects , Valproic Acid/therapeutic use
16.
Nervenarzt ; 66(2): 89-96, 1995 Feb.
Article in German | MEDLINE | ID: mdl-7715759

ABSTRACT

Advanced psychophysical tests, performed in 42 epileptic patients, show that the antiepileptic drugs phenytoin and carbamazepine can specifically affect the retinal function, while Valproic Acid and the epileptic seizures do not. The Farnsworth-Munsell 100-Hue and Panel D-15 désaturé tests revealed an accumulation of errors along the tritan/tetartan axis (blue colour vision deficiencies) and a high total error score. The same defect was shown by measurement of the spectral sensitivity functions. The results obtained for mesopic vision and especially glare sensitivity measured by nyktometry were markedly affected in these patients compared to a normal population. The enhanced sensitivity to glare is mainly the only one symptom complained by the patient. We propose a screening method for early detection of phenytoin- and carbamazepine-induced neurotoxicity. The literature of ocular side effects of anticonvulsant drugs is carefully reviewed.


Subject(s)
Anticonvulsants/adverse effects , Carbamazepine/adverse effects , Color Vision Defects/chemically induced , Contrast Sensitivity/drug effects , Epilepsy/drug therapy , Night Blindness/chemically induced , Phenytoin/adverse effects , Adolescent , Adult , Anticonvulsants/therapeutic use , Carbamazepine/therapeutic use , Child , Color Perception Tests , Female , Humans , Male , Phenytoin/therapeutic use
17.
Behav Brain Res ; 55(2): 213-21, 1993 Jun 30.
Article in English | MEDLINE | ID: mdl-8102850

ABSTRACT

The present study examines two characteristic traits of the hippocampus in apomorphine-susceptible (APO-SUS) and apomorphine-unsusceptible (APO-UNSUS) Wistar rat lines. Since hippocampal mossy fibers contain among others dynorphin B as transmitter, a radioimmunoassay was used to analyze the hippocampal dynorphin B expression in response to novelty in these lines. Dynorphin B expression at the end of the baseline condition was greater in APO-SUS rats than in APO-UNSUS rats, while exposure to novelty decreased and increased the dynorphin B expression in APO-SUS and APO-UNSUS rats, respectively. These interline differences in dynorphin B expression could be due to (a) an interline difference in the size of the mossy fiber terminal fields, (b) an interline difference in the regulation of the firing rate of mossy fibers by corticosteroids, and/or (c) an interline difference in the release of corticosteroids in response to novelty. Since the size of the mossy fiber infra/intrapyramidal terminal field is inversely related to two-way active avoidance performance, APO-SUS and APO-UNSUS rats (n = 9 per line) were given this task: APO-UNSUS rats performed much better than APO-SUS rats. It is concluded that the neurochemical and behavioural function of the hippocampus significantly differs between lines. Given the already known interline differences in the function of the nucleus accumbens, the present results provide a new avenue in search for the functional relationship between the hippocampus and the nucleus accumbens.


Subject(s)
Apomorphine/pharmacology , Arousal/drug effects , Avoidance Learning/drug effects , Dynorphins/analogs & derivatives , Endorphins/genetics , Hippocampus/drug effects , Nucleus Accumbens/drug effects , Animals , Arousal/physiology , Avoidance Learning/physiology , Dominance, Cerebral/drug effects , Dominance, Cerebral/physiology , Dynorphins/genetics , Gene Expression/physiology , Hippocampus/physiology , Male , Motor Activity/drug effects , Motor Activity/physiology , Neural Pathways/drug effects , Neural Pathways/physiology , Nucleus Accumbens/physiology , Rats , Rats, Wistar , Social Environment , Stereotyped Behavior/drug effects , Stereotyped Behavior/physiology
18.
NeuroRehabilitation ; 3(3): 53-65, 1993.
Article in English | MEDLINE | ID: mdl-24526071

ABSTRACT

Brain tumors are the most common type of solid tumors in childhood. It has only been over the past 20 years that the majority of children with intracranial tumors are surviving. Children who survive their tumors may do so with significant disabilities resulting from the tumor or its treatment, and are presenting a new challenge in pediatric rehabilitation. In this article, we will discuss the epidemiology and characteristics of the major types of brain tumors that occur in children, the multimodality approach to tumor treatment along with the major complications of the interventions that have implications for the quality of survival, the types of deficits in function that occur most commonly in children who survive their tumors, and the team approach to rehabilitation of children with disabilities due to brain tumors.

19.
Headache ; 31(4): 205-9, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1646775

ABSTRACT

In a pilot study (5 patients) we investigated the effects of subcutaneous sumatriptan, a 5-HT1-like receptor agonist, on headache experienced during the withdrawal period of drug-induced headache. The pilot study indicated that the substance was effective mostly in patients who originally suffered from migraine. In a patient with tension headache the substance was less effective. In a second double-blind study on six migraine patients with severe drug-induced headache, the drug was highly effective in ameliorating headache and autonomic disturbances. Blood flow velocities measured in extracranial parts of internal and external carotid arteries by duplex-sonography and in middle cerebral and basilar arteries by transcranial Doppler showed no changes after administration of sumatriptan or placebo. This result suggests sumatriptan does not act primarily via constriction of the large cerebral arteries.


Subject(s)
Headache/drug therapy , Indoles/therapeutic use , Substance Withdrawal Syndrome/drug therapy , Sulfonamides/therapeutic use , Vasoconstrictor Agents/therapeutic use , Adult , Cerebral Arteries/diagnostic imaging , Cerebrovascular Circulation/physiology , Double-Blind Method , Ergotamine/adverse effects , Female , Headache/chemically induced , Headache/physiopathology , Humans , Indoles/administration & dosage , Indoles/blood , Injections, Subcutaneous , Male , Middle Aged , Migraine Disorders/drug therapy , Migraine Disorders/physiopathology , Pain Measurement , Pilot Projects , Substance Withdrawal Syndrome/physiopathology , Sulfonamides/administration & dosage , Sulfonamides/blood , Sumatriptan , Ultrasonography , Vasoconstrictor Agents/administration & dosage , Vasoconstrictor Agents/blood
20.
Eur Neurol ; 31(6): 388-90, 1991.
Article in English | MEDLINE | ID: mdl-1756763

ABSTRACT

We have investigated the effect of piracetam on photoparoxysmal responses in 3 patients with progressive myoclonus epilepsy. With doses of up to 10 g/day, elimination of photoparoxysmal responses was achieved in all 3 patients. Corresponding to EEG improvement, the clinical performance improved slightly in 2 patients and definitely in 1 patient when piracetam was added to their medication of valproate and clonazepam. According to our data, medical treatment of myoclonus with piracetam is justified particularly in myoclonus of cortical origin.


Subject(s)
Electroencephalography/drug effects , Electromyography/drug effects , Epilepsies, Myoclonic/drug therapy , Epilepsies, Myoclonic/physiopathology , Photic Stimulation , Piracetam/therapeutic use , Adolescent , Clonazepam/therapeutic use , Dose-Response Relationship, Drug , Drug Therapy, Combination , Epilepsies, Myoclonic/diagnosis , Female , Humans , Male , Valproic Acid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...